195
Views
1
CrossRef citations to date
0
Altmetric
Reviews

Cyclin-Dependent Kinases as Drug Targets for Cell Growth and Proliferation Disorders. A Role for Systems Biology Approach in Drug Development. Part I—Cyclin-Dependent Kinases as Drug Targets in Cancer

Pages 2583-2586 | Published online: 16 Apr 2014

REFERENCES

  • Abe J., Zhou W., Taguchi J., Takuwa N., Miki K., Okazaki H., Kurokawa K., Kumada M., Takuwa Y. (1994) Biochem. Biophys. Res. Commun., 198, 16–24.
  • Adams P.D., Li X. Sellers W.R., Baker K.B., Leng X., Harper J.W., Taya Y., Kaelin W.G. Jr. (1999) Mol. cell. Biol., 19, 1068–1080.
  • Aldoss LT., Tashi T., Ganti A.K. (2009) Expert. opin. Investig. Drugs, 18, 1957–1965.
  • Appleyard M.V., O'Neill M.A., Murray K.E., Paulin F.E., Bray S.E., Kernohan N.M., Levison D.A., Lane D.P., Thompson A.M. (2009) Int. J. cancer, 124, 465–472.
  • Atanasova G., Isaeva A., Zhelev N., Poumay Y., Mitev V. (2007) Oncol. Rep., 8(4), 999–1005.
  • Atanasova G., Jans R., Zhelev N., Mitev V., Poumay Y. (2005) Biochem. Pharmacol., 70(6), 824–836.
  • Atanasova G., Jans R., Zhelev N., Mitev V., Poumay Y.G. (2004) J. Inves. Derm. Symp. P., 122(3),A95.
  • de Azevedo W.F., Leclerc S., Meijer L., Havlicek L., Strnad M., Kim S.H. (1997) Eur. J. Biochem., 243(1–2), 518–526.
  • de Azevedo W.F. Jr., Gaspar R.T., Canduri F., Camera J.C. Jr., Freitas da Silveira N.J. (2002) Biochem. Biophys. Res. Commun., 297, 1154–1158.
  • Ball K.L., Lain S., Fâhraeus R., Smythe C., Lane D.P. (1997) Curr. Biol., 7, 71–80.
  • Benson C., White J., De Bono J., O'Donnell A., Raynaud F., Cruickshank C., McGrath H., Walton M., Workman P., Kaye S., Cassidy J., Gianella-Borradori A., Judson I., Twelves C. (2007) Brit. J. Cancer, 96, 29–37.
  • Blagden S. and de Bono J. (2005) Curr Drug Targets, 6, 325–335.
  • Canduri F., Uchoa H.B., de Azevedo W.F. Jr. (2004) Biochem. Biophys. Res. Commun., 324, 661–666.
  • Carroll J.S., Swarbrick A., Musgrove E.A., Sutherland R.L. (2002) Cancer Res., 62, 3126–3131.
  • Chakarov S., Russev G. (2010) Biotechnol. Biotech. Eq., 24(2), 1804–1806.
  • Chen Y.N.P., Sharma S.K., Ramsey T.M., Jiang L., Martin M.S., Baker K., Adams P.D., Bair K.W., Kaelin W.G. (1999) Proc. Natl. Acad. Sci. U.S.A., 96, 4325–4329.
  • Christian B.A., Grever M.R., Byrd J.C., Lin T.S. (2007) Flavopiridol in the treatment of chronic lymphocytic leukemia. Curr. Opin. Oncol., 19, 573–578.
  • Collins I., Garrett M.D. (2005) Curr Opin Pharmacol., 5(4), 366–373.
  • Czajlik A., Meskó E., Penke B., Perczel A. (2002) J. Pept. Sci., 8, 151–171.
  • Dang C.V. (2010) Cell Cycle, 9, 3884–3886.
  • Dang C.V., Hamaker M., Sun P., Le A., Gao P. (2011) J. Mol. Med. (Berl.), 89, 205–212.
  • DeBerardinis R.J., Mancuso A., Daikhin E., Nissim I., Yudkoff M., Wehrli S., Thompson C.B. (2007) Proc. Natl. Acad. Sci. U.S.A., 104, 19345–19350.
  • Dineva M., Chakurov S., Bratovanova E., Devedjiev I., Petkov D. (1993) Bioorg. Med. Chem., 1, 411–414.
  • Feron O. (2009) Radiother. Oncol., 92, 329–333.
  • Fischer P.M. and Gianella-Borradori A. (2005) Expert opin. Investig. Drugs, 14, 457–477.
  • Fischer P.M. and Lane D.P. (2000) Curr. Med. Chem., 7, 1213–1245.
  • Fischer P.M., Zhelev N.Z., Wang S., Melville J.E., Fåhraeus R., Lane D.P. (2000) J. Pept. Res., 55(2), 163–172.
  • Fischer P.M., Zheleva D.I., McInnes C., Gavine A.L., Zhelev N.Z., Lane D.P. (2001) Clin. Cancer Res., 7(11S),3821S–3822S.
  • Foster J.S., Henley D.C., Bukovsky A., Seth P., Wimalasena J. (2001) Mol. Cell. Biol., 21, 794–810.
  • Hikita T., Oneyama C., Okada M. (2010) Genes Cells., 15, 1051–1062.
  • Jain KK. (2009) Drug Disc. Today, 10, 1435–1442.
  • Karapetyan G., Chakrabarty K., Hein M., Langer P. (2011) chem. Med. chem., 6, 25–37.
  • Kong N., Fotouhi N., Wovkulich P.M., Roberts J. (2003) Drugs Fut., 28, 881.
  • Kovarova H., Hajduch M., Korinkova G., Halada P., Krupickova S., Gouldsworthy A., Zhelev N.Z., Strnad M. (2000) Electrophoresis, 21, 3757–3764.
  • Korinkova G., Cwiertka K., Paprskarova M., Dzubak P., Hajduch M. (2010) Neoplasma, 57, 161–169.
  • Krystof V., Lenobel R., Havlícek L., Kuzma M., Strnad M. (2002) Bioorg. Med. Chem. Lett., 12, 3283–3286.
  • Legraverend M., Tunnah P., Noble M., Ducrot P., Ludwig O., Grierson D.S., Leost M., Meijer L., Endicott J. (2000) J. Med. Chem., 43, 1282–1292.
  • Leitch A.E., Haslett C., Rossi A.G. (2009) Br. J. Pharmacol., 158, 1004–1016.
  • Leitch A.E., Riley N.A., Sheldrake T.A., Festa M., Fox S., Duffin R., Haslett C., Rossi A.G. (2010) Eur. J. Immunol., 40, 1127–1138.
  • Le Tourneau C., Faivre S., Laurence V., Delbaldo C., Vera K., Girre V., Chiao J., Armour S., Frame S., Green S.R., Gianella-Borradori A., Diéras V., Raymond E. (2010) Eur. J. Cancer., 46, 3243–3250.
  • Letoha T., Gaál S., Somlai C., Czajlik A., Perczel A., Penke B. (2003) J. Mol. Recognit., 16, 272–279.
  • Maćkowiak M., Kolasiewicz W., Markowicz-Kula K., Wedzony K. (2005) Pharmacol. Rep., 57, 845–849.
  • Maggiorella L., Deutsch E., Frascogna V., Chavaudra N., Jeanson L., Milliat F., Eschwege F., Bourhis J. (2003) Cancer Res., 63, 2513–2517.
  • McClue S.J., Blake D., Clarke R., Cowan A., Cummings L., Fischer P.M. MacKenzie M., Melville J., Stewart K., Wang S., Zhelev N., Zheleva D., Lane D.P. (2002) Int. J. Cancer, 102(5), 463–468.
  • Meijer L., Raymond E. (2003) Acc. Chem. Res., 36, 417–425.
  • Mihara M., Shintani S., Kiyota A., Matsumura T., Wong D.T. (2002) Int. J. Oncol., 21, 95–101.
  • Milovanceva-Popovska M., Kunter U., Ostendorf T., Petermann A., Rong S., Eitner F., Kerjaschki D., Barnett A., Floege J. (2005) Kidney Int., 67, 1362–1370.
  • Nestler E. J., Greengard P. (1984) Protein Phosphorylation in the Nervous System. New York, Wiley.
  • Nouspikel T., Hanawalt P.C. (2000) Mol. Cell. Biol., 20, 1562–1570.
  • Nouspikel T.P., Hyka-Nouspikel N., Hanawalt P.C. (2006) Mol.Cell. Biol., 26, 8722–8730.
  • Nutley B.P., Raynaud F.I., Wilson S.C., Fischer P.M., Hayes A., Goddard P.M., McClue S.J., Jarman M., Lane D.P., Workman P. (2005) Mol. Cancer Ther., 4, 125–139.
  • Pagano M., Draetta G., Jansen-Dürr P. (1992) Science, 255, 1144–1147.
  • Petkova R., Chakarov S., Ganev V. (2007) Biotechnol. Biotech. Eq., 21(3), 286–293.
  • Raje N., Kumar S., Hideshima T., Roccaro A., Ishitsuka K., Yasui H., Shiraishi N., Chauhan D., Munshi N.C., Green S.R., Anderson K.C. (2005) Blood, 106, 1042–1047.
  • Ravitz M.J., Wenner C.E. (1997) Adv. Cancer Res., 71, 165–207.
  • Raynaud F.I., Whittaker S.R., Fischer P.M., McClue S., Walton M.I., Barrie S.E., Garrett M.D., Rogers P., Clarke S.J., Kelland L.R., Valenti M., Brunton L., Eccles S., Lane D.P., Workman P. (2005) Clin Cancer Res., 11, 4875–4887.
  • Rizzolio F., Tuccinardi T., Caligiuri I., Lucchetti C., Giordano A. (2010) Curr. Drug. Targets, 11, 279–290.
  • Rossi A.G., Sawatzky D.A., Walker A., Ward C., Sheldrake T.A., Riley N.A., Caldicott A., Martinez-Losa M., Walker T.R., Duffin R., Gray M., Crescenzi E., Martin M.C., Brady H.J., Savill J.S., Dransfield I., Haslett C. (2006) Nat. Med., 12(9):1056–1064.
  • Sánchez C., Méndez C., Salas J.A. (2006) J. Ind. Microbiol. Biotechnol., 33, 560–568.
  • Schulman H. (1995) Curr. Opin. Neurobiol., 5, 375–381.
  • Senderowicz A.M. (2005) Prog Drug Res., 63, 183–206.
  • Smyth L.A., Matthews T.P., Collins I (2011) Bioorg. Med. Chem., 19, 3569–3578.
  • Song H., Vita M., Sallam H., Tehranchi R., Nilsson C., Sidén A., Hassan Z. (2007) Cancer Chemother. Pharmacol., 60, 841–849.
  • Tickenbrock L., Müller-Tidow C., Berdel W.E., Serve H. (2006) Expert Opin. Emerg. Drugs., 11, 153–165.
  • Tummala H., Khalil H.S., Nikolova E., Mitev V., Zhelev N. (2011) Curr. Opin. Biotech., 22(S1),S25.
  • Tummala H., Khalil H.S., Zhelev N. (2011) Biotechnol. Biotech. Eq., 25(3), 2443–2446.
  • Wang S., Blake D., Clarke R., Duff S., McClue S., McInnes C., Melville J., Stewart K., Taylor P., Westwood R., Wood G., Wu S., Zhelev N.Z., Zheleva D. I., Walkinshaw M., Lane D.P., Fischer P.M. (2002) Proc. Am. Assoc. Canc. Res., 43, 848.
  • Whittaker S., Walton M., Kelland L., Garrett M., Zhelev N., Workman P. (2001) Proc. Am. Assoc. Canc. Res., 42, 926.
  • Wilson S.C., Atrash B., Barlow C., Eccles S., Fischer P.M., Hayes A., Kelland L., Jackson W., Jarman M., Mirza A., Moreno J., Nutley B.P., Raynaud F.I., Sheldrake P., Walton M., Westwood R., Whittaker S., Workman P., McDonald E. (2011) Bioorg. Med. Chem. (Epub ahead of print)
  • Wu P.C., Tai M.H., Hu D.N., Lai C.H., Chen Y.H., Wu Y.C., Tsai C.L., Shin S.J., Kuo H.K. (2008) J. Ocul. Pharmacol. Ther., 24, 25–33.
  • Xu X., Yamamoto H. Liu G., Ito Y., Ngan C.Y., Kondo M., Nagano H., Dono K., Sekimoto M., Monden M. (2008) Int. J. Mol. Med., 21, 145–152.
  • Zhang G.J., Safran M., Wei W., Sorensen E., Lassota P., Zhelev N., Neuberg D.S. Shapiro G., Kaelin W. G. Jr. (2004) Nat. Med., 10, 643–648.
  • Zheleva D.I., McInnes C., Gavine A.L., Zhelev N.Z., Fischer P.M., Lane D.P. (2002) J Pept. Res., 60, 257–270.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.